logo

The much awaited results of the STAMPEDE study of abiraterone for hormone naive prostate cancer was simultataneously presented at #ASCO17 and published ‘on line ahead of prin[...]
Every week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full arti[...]
This patient is undergoing radiotherapy for recurrent prostate cancer. Images from Fodor et al, BJUI 2017.[...]
Kabiguru Rabindranath Tagore is perpetually present in the Bengali memory and is a part and parcel of the Indian cultural fabric even after 75 years of his demise. The Bard of Beng[...]
Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full arti[...]
For the first time, Storebjerg et al. [1] describe the prevalence of the HOXB13 G84E mutation in a Danish population and its association with prostate cancer risk and features indi[...]
Every Month the Editor-in-Chief selects an Article of the Month from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full ar[...]
Introduction In the last few years there have been concerted attempts at using the power of the immune system as an effective treatment option for cancer. This has become possible [...]
After briefly venturing to tropical Cairns in 2015, the Asia-Pacific Prostate Cancer Conference returned to its traditional home in Melbourne for its 17th edition in 2016 (#APCC16)[...]